Structure and Property Guided Design of Cell Permeable Peptidic Degraders
Jakob Fuhrmann
Principal Scientist, Genentech
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.
Jakob received his PhD in molecular/structural biology from the University of Vienna, Austria. Thereafter, he performed his postdoctoral training in chemistry at the Scripps Research Institute, supported by an Erwin Schroedinger fellowship and EMBO long term fellowship. Jakob is currently a Principal Scientist at Genentech in South San Francisco, where he manages a chemical biology lab in the field of peptide and peptidomimetic drug discovery. He has extensive experience working on constrained peptides, structure-guided designs as well as property-based lead optimization.